R
ReneuBio develops small molecule therapeutics aimed at restoring the regenerative capacity of the aging brain. The company utilizes a proprietary Innovation Engine to screen and identify targets directly within aged brain tissue for drug discovery. This approach focuses on reactivating dormant neural stem cells to promote resilience and recovery in age-related neurological disorders like stroke and Alzheimer's disease.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ReneuBio develops small molecule therapeutics aimed at restoring the regenerative capacity of the aging brain. The company utilizes a proprietary Innovation Engine to screen and identify targets directly within aged brain tissue for drug discovery. This approach focuses on reactivating dormant neural stem cells to promote resilience and recovery in age-related neurological disorders like stroke and Alzheimer's disease.